Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adverum Biotechnologies
Adverum Biotechnologies
(ADVM)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ziv-aflibercept
colorectal neoplasms
,
retinitis pigmentosa
,
retinitis
,
retinal diseases
,
premature birth
,
retinopathy of prematurity
,
glaucoma
,
neovascular glaucoma
,
myopia
,
eye diseases
,
diabetes mellitus
,
neoplasm metastasis
,
retinal degeneration
,
type 2 diabetes mellitus
,
type 1 diabetes mellitus
,
degenerative myopia
,
macular degeneration
,
macular edema
,
edema
,
wet macular degeneration
,
retinal vein occlusion
,
choroidal neovascularization
,
pathologic neovascularization
,
polypoidal choroidal vasculopathy
,
vascular diseases
,
diabetic retinopathy
,
hemorrhage
,
retinal neovascularization
,
caregiver burden
,
newborn infant diseases
,
uveitis
,
inflammation
,
endophthalmitis
,
vision disorders
,
low vision
Alpha1-proteinase inhibitor
fibrosis
,
cystic fibrosis
,
pneumonia
,
inflammation
,
eosinophilic esophagitis
,
esophagitis
,
graft vs host disease
,
hiv infections
,
acquired immunodeficiency syndrome
,
job syndrome
,
alpha 1-antitrypsin deficiency
,
emphysema
,
pulmonary emphysema
,
hemophilia b
,
chronic obstructive pulmonary disease
,
obstructive lung diseases
,
smoking
Corticoids
macular degeneration
,
wet macular degeneration
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use